-
Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page
Just when you thought it couldn’t get worse in Ophthalmology…
- Thread starter anonymous
- Start date
-
- Tags
- None
Didn’t that guy get fired from Bausch and Lomb?
The “skid stain in the fruit of the looms” that I work with is bat shite nuts, please end this MS/DeMS escapade
These goals… LOLOLOL
officially shutting it down for 2024. good luck
officially shutting it down for 2024. good luck
Lucky! Did you know if you take Dec 23-24 off it counts towards your next year of vacation.
I am Up for healthy competition. Q3 goals were lofty and I came in at 70 percent attainment for HD. This quarter they went a crazy amount higher. WTF! This seems not even possible…. And I am not a complainer this just seems far fetched!
Can they put Ashish and our Goaling on the next pulse survey? Asking for myself and roughly 80 friends hehe
not happening. Seen our stock price today? They are going to be treating us like sled dogs until further notice
If the stock goes lower, that’s a great time to buy
it will rebound hopefully